Chimeric Therapeutics
Chimeric - Model CHM 3301 (Undisclosed CAR NK) -NK Cell Derived Allogeneic Therapies
CHM 3301 (Undisclosed CAR NK) will be developed on the next generation CORE-NK platform leveraging a currently undisclosed Chimeric Antigen Receptor.
Most popular related searches
